Gunpo-si, Gyeonggi-do, South Korea

Hahnsun Jung

This inventor holds 1 USPTO granted patent. Top assignee: Paean Biotechnology Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hahnsun Jung. Retrieved from https://idiyas.com/inventor/hahnsun-jung-ra3jmloi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hahnsun Jung: Innovator in Pharmaceutical Composition

Introduction

Hahnsun Jung is a notable inventor based in Gunpo-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of myositis. His innovative approach has led to the development of a unique pharmaceutical composition that utilizes isolated mitochondria as an active ingredient.

Latest Patents

Hahnsun Jung holds a patent for a "Pharmaceutical Composition for Preventing or Treating Myositis, Comprising Isolated Mitochondria as Active Ingredient." This patent highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Jung is currently employed at Paean Biotechnology Inc., where he continues to work on groundbreaking research and development in the pharmaceutical sector. His expertise and dedication have positioned him as a valuable asset to his company and the industry at large.

Collaborations

Throughout his career, Hahnsun Jung has collaborated with talented individuals such as Kyuboem Han and Chun-Hyung Kim. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Hahnsun Jung's work in developing pharmaceutical compositions demonstrates his innovative spirit and dedication to improving healthcare. His contributions are paving the way for new treatments and advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…